Dr. Drew and his guests discuss what people should understand about the risks of breast cancer.
For five days as her husband lay in his hospital bed suffering from kidney cancer, Regina Holliday begged doctors and nurses for his medical records, and for five days she never received them.
For the first time, doctors said Monday they have found a pill that improves survival for people with liver cancer, a notoriously hard to treat disease diagnosed in more than half a million people globally each year
More than thirty years after President Nixon vowed to win the war on cancer, the battle rages on with no victor in sight. But that won't stop Big Pharma and biotechs alike from trying to entice investors next week with fresh reports on the hunt for a panacea.
The threat to Big Pharma is real - the nation's drugmakers stand to lose nearly seven percent of their sales to drugs going off patent this year - and more CEOs who don't get ahead of the problem could end up losing their jobs.
Wyeth filed with the FDA an application for an experimental drug that would extend the life of terminally ill kidney cancer patients, the company said Friday.
Sutent, an anti-cancer drug from Pfizer that's been on the market just a few months, shrank tumors and stopped them from spreading in the lungs and kidneys of patients, according to studies unveiled this weekend.
Dr. When most kids were learning to ride bikes, little Frank J. Rauscher III was learning the ins and outs of a cancer research lab.
An experimental drug combination from Wyeth helps women in the advanced stages of breast cancer live longer, the company said Thursday.
Fed up with an impersonal HMO? Wondering whether your doctor really knows best? Want the full story on a disease and its treatments from people who have it? Then surf, surf, surf.
A SMALL COMPANY called Biotherapeutics Inc., in Franklin, Tennessee, opened a private front in the war against cancer three years ago. At that point the new cancer-killing wonder drug Interleukin-2...